BRIEF-Royalty Pharma increases offer to acquire Elan

LONDON, June 7 Fri Jun 7, 2013 6:39am EDT

LONDON, June 7 (Reuters) - Royalty Pharma: * Royalty Pharma increases offer to acquire Elan * Increased offer, including CVR, potentially values Elan share at up to $15.50

if three CVR payment events occur * Offering upfront cash value of $4.9 billion for Tysabri royalty * Urges Elan stockholders to vote " against all" items on the agenda at the

Elan EGM * Will waive down acceptance threshold to 50% plus one share if all other

conditions to increased offer satisfied * Offer to lapse if theravance resolution or any of the other resolutions

approved by Elan investors at Elan EGM * Source text for Eikon:

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.